December 2021 Vol 7 No 6

A thorough overview of multiple myeloma, including an understanding of treatment options, the importance of patient and doctor communication, and an oncology navigator’s experience treating this form of blood cancer. Read More ›

At age 84, Inocencio Melendez-Schroder was diagnosed with stage IV leukemia and was told that chemotherapy and radiation would not be recommended. Soon after his death at home, his daughter, Barbara, was diagnosed with stage II leukemia and used her dad’s lessons to improve her prognosis. Read More ›

The December 2021 issue of CONQUER magazine is focused on prostate cancer and men’s attitude toward health. In her introduction, Lillie Shockney, RN, BS, MAS, HON-ONN-CG, highlights men’s reluctance to open up to others and their tendency to hide any sign of vulnerability, hindering discussions about their health and preventing emotional healing. Read More ›

In November 2021, the FDA approved the combination of subcutaneous Darzalex Faspro (daratumumab and hyaluronidase) plus Kyprolis (carfilzomib) and dexamethasone for adults with relapsed or refractory multiple myeloma who have received previous therapy. Read More ›

This article presents recent studies that shed light on racial disparities in the treatment of black and white men who are diagnosed with prostate cancer. Read More ›

Dr. Daniel Vorobiof provides an overview of prostate cancer, including prevention tips and risk factors, diagnosis, treatment options, and specific questions to consider asking your doctor. Read More ›

Douglas Herman, who lives with stage IV prostate cancer, highlights the strength that love provides, noting that giving and receiving love are both powerful in their own way. Read More ›

Losing weight and her appetite made Lydia Virgo go to the doctor to get a blood test, which showed a low iron count. Although exhibiting no pain, Lydia’s CT scan and colonoscopy revealed a tumor in her colon. Read More ›

In October 2021, the FDA approved the combination of Verzenio (abemaciclib), a CDK 4/6 inhibitor, plus endocrine therapy for adjuvant treatment (after surgery) of adults with HR-positive, HER2-negative, node-positive, early breast cancer that is at high risk of recurrence. Read More ›

Six months before he was diagnosed with stage IIIB colorectal cancer, both of Joe Bullock’s parents passed away. Chemotherapy hit him hard and stirred a mixture of depression and feelings of inadequacy as a husband and father. Then he discovered the power of opening up. Read More ›